ENTRY       K01500                      KO
NAME        E3.5.4.-
PATHWAY     ko00791  Atrazine degradation
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Metabolism
              Xenobiotics biodegradation and metabolism
               00791 Atrazine degradation
                K01500  E3.5.4.-;
            Enzymes [BR:ko01000]
             3. Hydrolases
              3.5  Acting on carbon-nitrogen bonds, other than peptide bonds
               3.5.4  In cyclic amidines
                3.5.4.-  
                 K01500  E3.5.4.-
DBLINKS     RN: R06970 R06971 R06972
GENES       HSA: 10930(APOBEC2) 200315(APOBEC3A) 200316(APOBEC3F) 27350(APOBEC3C) 403314(APOBEC4) 60489(APOBEC3G) 9582(APOBEC3B)
            PTR: 449577(APOBEC3G) 462675(APOBEC2) 470275(APOBEC3F) 743891(APOBEC3B)
            PPS: 100971498(APOBEC3B) 100980527(APOBEC2)
            GGO: 101152034(APOBEC2)
            PON: 100172314(APOBEC2) 100456583(APOBEC3B)
            MCC: 719677(APOBEC2)
            MCF: 102137856(APOBEC2)
            MMU: 11811(Apobec2) 80287(Apobec3)
            RNO: 301226(Apobec2)
            CGE: 100756679(Apobec2)
            HGL: 101720974(Apobec2)
            TUP: 102475059(APOBEC2)
            CFA: 481788(APOBEC2)
            AML: 100467627
            FCA: 101098384(APOBEC2)
            BTA: 509619(APOBEC2)
            BOM: 102283955(APOBEC2)
            PHD: 102339632(APOBEC2)
            CHX: 102186351(APOBEC2)
            SSC: 100156477 100518202
            CFR: 102520713(APOBEC2)
            ECB: 100066057(APOBEC2)
            MYB: 102261666(APOBEC2)
            MYD: 102774926(APOBEC2)
            PALE: 102886886(APOBEC2)
            MDO: 100030025(APOBEC2)
            SHR: 100916473(APOBEC2)
            OAA: 100087190(APOBEC2)
            GGA: 419915(APOBEC2)
            MGP: 100539356
            TGU: 100231368(APOBEC2)
            FAB: 101810835(APOBEC2)
            PHI: 102109316(APOBEC2)
            APLA: 101805151(APOBEC2)
            FPG: 101911818(APOBEC2)
            FCH: 102057716(APOBEC2)
            CLV: 102083456(APOBEC2)
            ASN: 102373069(APOBEC2)
            PSS: 102447070(APOBEC2)
            ACS: 100554228
            XLA: 444740(apobec2)
            XTR: 448374(apobec2)
            DRE: 503736(apobec2a) 567047(apobec2b)
            TRU: 101071263 101071689
            MZE: 101475259 101478792
            OLA: 101154950 101160551
            XMA: 102230214
            LCM: 102367316(APOBEC2)
            AFM: AFUA_2G13200 AFUA_3G07440 AFUA_7G01040
            PFA: PF13_0259
            TAN: TA18255
            PEN: PSEEN0949 PSEEN4389
            PAR: Psyc_1496(cumB)
            ACI: ACIAD3297
            AEH: Mlg_1017
            ABO: ABO_0821
            DNO: DNO_0579(tadA)
            REH: H16_B0862
            ERU: Erum5690
            ERW: ERWE_CDS_05970
            BRA: BRADO1146 BRADO6082
            BBT: BBta_1700 BBta_6907
            RPE: RPE_0931
            GBE: GbCGDNIH1_0457
            RHA: RHA1_ro04154
            AAU: AAur_0794
            FRA: Francci3_2714
            SEN: SACE_0662
            CTA: CTA_0920(yfhC)
            SUS: Acid_6428
            RBA: RB4423
            SYF: Synpcc7942_1856
            SYD: Syncc9605_1208
            SYR: SynRCC307_1293(tadA)
            SYX: SynWH7803_1344(tadA)
            AVA: Ava_2142
            GFO: GFO_1600 GFO_3469
REFERENCE   PMID:12683974
  AUTHORS   Wedekind JE, Dance GS, Sowden MP, Smith HC
  TITLE     Messenger RNA editing in mammals: new members of the APOBEC family seeking roles  in the family business.
  JOURNAL   Trends Genet 19:207-16 (2003)
///
